Targeted therapies in thyroid cancer: an extensive review of the literature.

Patients with progressive, metastatic, RAI-refractory differentiated thyroid cancer (DTC), as well as patients with advanced medullary (MTC) and anaplastic thyroid cancer represent a cohort for which therapeutic options are limited. The recent discoveries in the molecular mechanisms implicated in TC have provided insight of the pathogenesis and progression of disease. In that respect, targeted therapies have emerged as a promising alternative for the treatment of those patients.

A 29-year-old man with an unusual cause of an abscess.

A 29-year-old man with no medical history presented with a left scalp abscess and left temporal oedema. He was initially started on treatment for community acquired Methicillin-resistant Staphylococcus aureus with sulfamethoxazole and trimethoprim. Over the next 2 weeks, his swelling improved; however, he continued to have localised swelling and drainage from the area.